Expanded access

Expanded access

refers to any of the fda procedures (compassionate use, parallel track and treatment ind see) that distributes experimental drugs to patients who are failing on currently available treatments for their condition and also are unable to participate in ongoing clinical trials.


Please contribute to this project, if you have more information about this term feel free to edit this page



This page was last modified on 3 October 2005, at 21:16. This page has been accessed 757 times. 
What links here | Related changes | Permanent link